- Home
- RAYA vs FGEN Comparison
RAYA vs FGEN Comparison
Compare RAYA & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- FGEN
- Stock Information
- Founded
- RAYA 2019
- FGEN 1993
- Country
- RAYA China
- FGEN United States
- Employees
- RAYA N/A
- FGEN N/A
- Industry
- RAYA Metal Fabrications
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- FGEN Health Care
- Exchange
- RAYA Nasdaq
- FGEN Nasdaq
- Market Cap
- RAYA 32.5M
- FGEN 34.5M
- IPO Year
- RAYA 2022
- FGEN 2014
- Fundamental
- Price
- RAYA $1.19
- FGEN $0.40
- Analyst Decision
- RAYA
- FGEN
- Analyst Count
- RAYA 0
- FGEN 0
- Target Price
- RAYA N/A
- FGEN N/A
- AVG Volume (30 Days)
- RAYA 10.4K
- FGEN 996.1K
- Earning Date
- RAYA 07-09-2024
- FGEN 11-12-2024
- Dividend Yield
- RAYA N/A
- FGEN N/A
- EPS Growth
- RAYA N/A
- FGEN N/A
- EPS
- RAYA N/A
- FGEN N/A
- Revenue
- RAYA $22,816,585.00
- FGEN $180,015,000.00
- Revenue This Year
- RAYA $64.53
- FGEN $19.67
- Revenue Next Year
- RAYA $9.61
- FGEN N/A
- P/E Ratio
- RAYA N/A
- FGEN N/A
- Revenue Growth
- RAYA N/A
- FGEN 16.15
- 52 Week Low
- RAYA $0.44
- FGEN $0.18
- 52 Week High
- RAYA $1.78
- FGEN $2.93
- Technical
- Relative Strength Index (RSI)
- RAYA 47.67
- FGEN 58.65
- Support Level
- RAYA $1.10
- FGEN $0.34
- Resistance Level
- RAYA $1.29
- FGEN $0.37
- Average True Range (ATR)
- RAYA 0.10
- FGEN 0.04
- MACD
- RAYA -0.01
- FGEN -0.00
- Stochastic Oscillator
- RAYA 21.95
- FGEN 76.07
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.